Consultations

You are here

Avis de consultation 27-MED-2024 NEOMYCINE COLLY 0.35%

by communication / 17 Mar, 2024

AVIS DE CONSULTATION N°24-MED-2024 - ACIDE FUSIDIQUE SEL DE SODIUM PDE DERM 2G%

by communication / 13 Mar, 2024

AVIS DE CONSULTATION N°23-MED-2024 - ACICLOVIR INJ 250 MG

by communication / 13 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°19-MED-2024 - N-ACETYLCYSTEINE INJ 5G-25ML

by communication / 13 Mar, 2024

AVIS D'ATTRIBUTION PROVISOIRE CONSULTATION N°05-MED2024 - ACIDE TRANEXAMIQUE INJ 500MG-5ML

by communication / 12 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°17-MED-2024 - LAMIVUDINE 150MG COMP

by communication / 12 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°18-MED-2024 - NEVIRAPINE SUSP BUV 50MG-5ML

by communication / 12 Mar, 2024

AVIS DE PROROGATION 2 - CONSULTATION N°07-MED-2024 HYDORCORTISONE HEMISUCCINATE INJ 500MG

by communication / 12 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°15-MED-2024 - PRALIDOXIME INJ 200MG

by communication / 11 Mar, 2024

AVIS DE PROROGATION CONSULTATION N°14-MED-2024 - BROMHEXINE CHL INJ 4MG-2ML

by communication / 11 Mar, 2024

Pages

09789332719.png